Tulopafant
Alternative Names: RP 59227Latest Information Update: 24 Aug 1994
At a glance
- Originator Aventis
- Class Antiasthmatics
- Mechanism of Action Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma